Skip to main content
NIBEC CO., LTD. logo

NIBEC CO., LTD. — Investor Relations & Filings

Ticker · 138610 ISIN · KR7138610001 KO Manufacturing
Open in API
Filings indexed 218 across all filing types
Latest filing 2024-03-21 Audit Report / Informat…
Country KR South Korea
Listing KO 138610

About NIBEC CO., LTD.

https://nibec.co.kr/en/

NIBEC CO., LTD. is a biotechnology company specializing in the research, development, and commercialization of healthcare solutions centered on proprietary peptide technology. The company's core activities involve the manufacturing of tissue regenerative biomaterials, such as dental bone grafts and collagen-based products, as well as biomaterial-based medical devices. In addition to its focus on regenerative medicine, NIBEC develops and markets a range of dental care and cosmetic products. The company is also actively engaged in the research and development of novel peptide-based drugs and bio-fusion technologies to address various therapeutic needs.

Recent filings

Filing Released Lang Actions
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from the company 'NIBEC' titled 'Audit Report Submission' (감사보고서 제출). It provides a summary of the audit opinion, key financial data, and capital impairment status as required by the Korea Exchange (KRX). While it contains financial data, it is a short, standardized announcement form (under 5,000 characters) notifying the market that the audit report has been submitted, rather than the full, multi-page audit report document itself. Therefore, it falls under the 'Report Publication Announcement' (RPA) category. FY 2023
2024-03-21 Korean
사업보고서 (2023.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the 20th fiscal year (2023) of NIBEC Co., Ltd. It contains comprehensive information including company overview, business activities, capital changes, and financial-related disclosures. This is the standard Korean regulatory filing equivalent to an Annual Report (10-K). FY 2023
2024-03-21 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Solicitation of Proxy Reference Document) for the company 'NIBEC'. It contains detailed information regarding the upcoming Annual General Meeting (AGM), including the agenda items (approval of financial statements, election of directors, and remuneration limits), candidate profiles for board positions, and proxy voting instructions. This document is a standard regulatory filing in South Korea used to solicit shareholder votes for an AGM, which falls under the 'Proxy Solicitation & Information Statement' category.
2024-03-12 Korean
주주총회소집공고
AGM Information Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Nibec Co., Ltd. It contains the agenda for the upcoming Annual General Meeting (AGM), including the approval of financial statements, election of directors, and remuneration limits. It also includes detailed financial statements (balance sheet, income statement, etc.) and governance information as part of the meeting materials. According to the filing definitions, materials shared for an AGM are classified as AGM-R.
2024-03-12 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (NIBEC) announcing a significant change (over 30%) in revenue or profit/loss structure. This type of disclosure is a standard financial announcement required by stock exchanges to inform investors of material changes in financial performance before the final audit is completed. It fits the definition of an Earnings Release (ER) as it provides key financial highlights and the reasons for the variance. FY 2023
2024-03-12 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by the company NIBEC. It outlines the date, location, and agenda items for the upcoming Annual General Meeting, including the approval of financial statements, election of directors, and remuneration limits. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the meeting and request their participation/votes.
2024-03-12 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.